ENTRY       D00333                      Drug
NAME        Ganciclovir (JAN/USP/INN);
            Cytovene (TN);
            Vitrasert (TN);
            Zirgan (TN)
PRODUCT     GANCICLOVIR (EXELA PHARMA SCIENCES)
            ZIRGAN (Bausch & Lomb Incorporated)
FORMULA     C9H13N5O4
EXACT_MASS  255.0968
MOL_WEIGHT  255.2306
CLASS       Antiviral
             DG02840  Anti-herpesvirus agent
             DG01937  Anti-cytomegalovirus agent
REMARK      Same as: C07019
            Therapeutic category: 6250
            ATC code: J05AB06 S01AD09
            Chemical structure group: DG00646
            Product (DG00646): D00333<JP/US> D04301<US>
EFFICACY    Antiviral, DNA polymerase inhibitor
  DISEASE   CMV retinitis, Prevention of CMV disease [DS:H00368]
            Acute herpetic keratitis [DS:H00365]
TARGET      HCMV DNA polymerase [KO:K18964]
            Herpesvirus DNA polymerase [KO:K18964]
  PATHWAY   ko03240(K18964+K18964)  Viral replication
INTERACTION  
STR_MAP     map07044  Antiviral agents
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
                 J05AB06 Ganciclovir
                  D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01A ANTIINFECTIVES
                S01AD Antivirals
                 S01AD09 Ganciclovir
                  D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-cytomegalovirus (CMV) Agents
               Ganciclovir
                D00333  Ganciclovir (JAN/USP/INN)
             Ophthalmic Agents
              Ophthalmic Anti-Infectives
               Antiviral, Ophthalmic
                Ganciclovir
                 D00333  Ganciclovir (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00333  Ganciclovir (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG02840  Anti-herpesvirus agent
               DG00646  Ganciclovir
                D00333  Ganciclovir
              DG01937  Anti-cytomegalovirus agent
               DG00646  Ganciclovir
                D00333  Ganciclovir
            Drug classes [BR:br08332]
             Antiviral
              DG02840  Anti-herpesvirus agent
               D00333  Ganciclovir
              DG01937  Anti-cytomegalovirus agent
               D00333  Ganciclovir
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               Herpesvirus DNA polymerase inhibitor
                D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;
            Prodrugs [br08324.html]
             D00333
            Drug groups [BR:br08330]
             Antiviral
              DG02840  Anti-herpesvirus agent
               DG00646  Ganciclovir
              DG01937  Anti-cytomegalovirus agent
               DG00646  Ganciclovir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               Herpesvirus DNA polymerase inhibitor
                DG00646  Ganciclovir
DBLINKS     CAS: 82410-32-0
            PubChem: 7847399
            ChEBI: 465284
            PDB-CCD: GA2
            LigandBox: D00333
            NIKKAJI: J22.096E
ATOM        18
            1   N4y N    23.5894  -15.7792
            2   C8y C    24.8354  -15.3006
            3   C8y C    24.8570  -13.9009
            4   N5x N    23.5108  -13.5146
            5   C8x C    22.7274  -14.6754
            6   N5x N    26.2117  -15.9583
            7   C8y C    27.3295  -15.2166
            8   N4x N    27.2810  -13.8170
            9   C8y C    26.0446  -13.1592
            10  O5x O    26.0667  -11.7758
            11  N1a N    28.5757  -15.8792
            12  C1b C    23.5894  -17.1792
            13  O2a O    22.3901  -17.8713
            14  C1c C    21.1762  -17.1701
            15  C1b C    19.9977  -17.8502
            16  C1b C    21.1759  -15.7504
            17  O1a O    19.9890  -15.0651
            18  O1a O    18.8022  -17.1595
BOND        19
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     1   5 1
            6     2   6 1
            7     6   7 2
            8     7   8 1
            9     8   9 1
            10    3   9 1
            11    9  10 2
            12    7  11 1
            13    1  12 1
            14   12  13 1
            15   13  14 1
            16   14  15 1
            17   14  16 1
            18   16  17 1
            19   15  18 1
///
